Type 2 Diabetes in 2025
Overview & Synopsis
Type 2 diabetes is a complex metabolic disorder caused by several pathophysiologic mechanisms that affect about 10% percent of the global population. This book focuses on clinical and laboratory assessment of therapeutic effectiveness and recent management of type 2 diabetes. It includes six chapters that address topics such as anthropometric measures and predictors for risk and management of diabetes, assessment of personal glucometers for routine monitoring, the influence of physical exercise, and new and Interesting benefits of molecules like GLP-1 receptor agonists, tirzepatide, retatrutide, and glucagon in obesity and type 2 diabetes. Chapters also discuss the lived experience of diabetes self-management among the elderly in India, as well as the pathophysiological links and management strategies of sarcopenia in type 2 diabetes.
www.doabooks.org)
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Type 2 Diabetes in 2025 |
|---|---|
| Author / Organization | DOAB Contributor |
| Subject & Discipline | Endocrinology |
| Categories | Open Access Books |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
Directory of Open Access Books
(www.doabooks.org)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-262694 |
| Original Source Link | Visit Source Page on www.doabooks.org » |